New depression pill aims to lift mood in major trial
NCT ID NCT07485595
First seen Mar 20, 2026 · Last updated May 12, 2026 · Updated 15 times
Summary
This study tests a new tablet called JS1-1-01 in 180 adults aged 18-65 with moderate to severe depression. Participants will receive either the drug or a placebo to see if it safely improves mood. The main goal is to measure changes in depression scores over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Gang Wang
Beijing, Beijing Municipality, China
Conditions
Explore the condition pages connected to this study.